chr11-1753540-T-C
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001909.5(CTSD):āc.1202A>Gā(p.Asn401Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,612,900 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001909.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTSD | NM_001909.5 | c.1202A>G | p.Asn401Ser | missense_variant | 9/9 | ENST00000236671.7 | NP_001900.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTSD | ENST00000236671.7 | c.1202A>G | p.Asn401Ser | missense_variant | 9/9 | 1 | NM_001909.5 | ENSP00000236671.2 | ||
ENSG00000250644 | ENST00000636615.1 | c.1071+263A>G | intron_variant | 5 | ENSP00000490014.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152128Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000204 AC: 51AN: 250512Hom.: 0 AF XY: 0.000228 AC XY: 31AN XY: 135780
GnomAD4 exome AF: 0.000110 AC: 160AN: 1460772Hom.: 1 Cov.: 33 AF XY: 0.000113 AC XY: 82AN XY: 726728
GnomAD4 genome AF: 0.000112 AC: 17AN: 152128Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74314
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 28, 2019 | The p.N401S variant (also known as c.1202A>G), located in coding exon 9 of the CTSD gene, results from an A to G substitution at nucleotide position 1202. The asparagine at codon 401 is replaced by serine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 11, 2023 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge - |
Neuronal ceroid lipofuscinosis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at